Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
review
OA: closed
CC0
⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper identifies at least five distinct ovarian carcinoma subtypes based on histological features and molecular genetics.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. via openalex
- Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary via openalex
- Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer via openalex
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- <i>PIK3CA</i> mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma via openalex
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. via openalex
- Prognosis of Japanese Patients with Ovarian Clear Cell Carcinoma Associated with Pelvic Endometriosis: Clinicopathologic Evaluation via openalex
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex
- W1967450348 via openalex
- W1970131592 via openalex
- W1972706951 via openalex
- W1976564360 via openalex
- W1978015204 via openalex
- W1978088642 via openalex
- W1982961529 via openalex
- W1984463181 via openalex
- W1986818451 via openalex
- W1987029726 via openalex
- W1988175987 via openalex
- W1988519585 via openalex
- W1991055728 via openalex
- W1993685841 via openalex
- W1996737831 via openalex
- W1998411917 via openalex
- W1999835490 via openalex
- W2001877789 via openalex
- W2001970570 via openalex
- W2002046262 via openalex
- W2003273433 via openalex
- W2003811411 via openalex
- W2004144597 via openalex
- W2007269627 via openalex
- W2009985804 via openalex
- W2012136454 via openalex
- W2012683206 via openalex
- W2013107316 via openalex
- W2017040284 via openalex
- W2017408894 via openalex
- W2020053836 via openalex
- W2020582501 via openalex
- W2024022439 via openalex
- W2033501360 via openalex
- W2033670530 via openalex
- W2034846334 via openalex
- W2041634324 via openalex
- W2045153367 via openalex
- W2045555409 via openalex
- W2046240259 via openalex
- W2048677309 via openalex
- W2050428825 via openalex
- W2055344345 via openalex
- W2056739417 via openalex
- W2057004583 via openalex
- W2058836507 via openalex
- W2060063531 via openalex
- W2061265681 via openalex
- W2061395485 via openalex
- W2061945206 via openalex
- W2063130873 via openalex
- W2063961555 via openalex
- W2068014054 via openalex
- W2069185701 via openalex
- W2070369494 via openalex
- W2070756619 via openalex
- W2071912666 via openalex
- W2075480569 via openalex
- W2086757750 via openalex
- W2087074511 via openalex
- W2088989339 via openalex
- W2090853702 via openalex
- W2092999618 via openalex
- W2094978279 via openalex
- W2095085832 via openalex
- W2095613768 via openalex
- W2103490198 via openalex
- W2105580481 via openalex
- W2110956488 via openalex
- W2113021550 via openalex
- W2114852376 via openalex
- W2118228232 via openalex
- W2119913499 via openalex
- W2123696077 via openalex
- W2127037900 via openalex
- W2128904109 via openalex
- W2129355295 via openalex
- W2130344626 via openalex
- W2131593373 via openalex
- W2133257689 via openalex
- W2133464976 via openalex
- W2134936717 via openalex
- W2137074525 via openalex
- W2137257426 via openalex
- W2138644182 via openalex
- W2147459403 via openalex
- W2154692501 via openalex
- W2155222298 via openalex
- W2159134433 via openalex
- W2160234594 via openalex
- W2162832987 via openalex
- W2166310305 via openalex
Cited by (9)
- Epithelial ovarian cancer: The most common subtype 2025
- Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular Analysis 2024
- Predicting the risk of decreased ovarian reserve after surgical treatment of patients with deep infiltrative endometriosis using artificial intelligence 2024
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2023
- Differential Expression of Long Non-coding Ribonucleic Acid (RNA) Genes in Endometriosis-associated Ovarian Cancer (EAOC): A Pilot Meta-analysis for Pathological Insights and Potential Diagnostic Biomarker Identification 2022
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2022
- Endometriosis and Epithelial Ovarian Cancer: A Two-Sample Mendelian Randomization analysis 2022
- Clinically Suspected Dysgerminoma Sent for Frozen Section Confirmation: A Case With Review and Differential Diagnosis of Clear Cell Carcinoma 2020
- Endometriosis-assEndometriosis-associated ovarian tumors: morphological and immunohistochemical features 2019
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:43.094626+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK